Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

3.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.1K
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and outcome of transscleral fine-needle aspiration biopsy in uveal melanoma: 10-year experience in 347 cases.

Retina (Philadelphia, Pa.)·2026
Same author

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.

HemaSphere·2026
Same author

Molecular evolution of mosaic chromosome 18 copy-number alterations from gametes to hepatoblastoma.

JHEP reports : innovation in hepatology·2026
Same author

Phase I/II Study of the CDK2/9 Inhibitor Fadraciclib in Combination with Chemotherapy in Children with Advanced Malignancies: Arm K of the AcSé-ESMART Trial.

Targeted oncology·2026
Same author

Imaging of High-Risk Neuroblastoma: Recommendations From SIOPEN Radiology and Nuclear Medicine Specialty Committees.

Pediatric blood & cancer·2026
Same author

Residual Absolute Volume of Blastema as a Predictor of Clinical Outcomes in Patients With Wilms Tumor: A Report From the SIOP WT 2001 Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Related Experiment Video

Updated: Apr 30, 2026

Reconstruct Human Retinoblastoma In Vitro
06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

1.6K

[Retinoblastoma: recent advances].

Mathilde Jehanne1, Hervé Brisse2, Marion Gauthier-Villars3

  • 1CHU Félix-Guyon, Service d'oncologie et hématologie pédiatrique, Saint-Denis, La Réunion.

Bulletin Du Cancer
|May 6, 2014
PubMed
Summary
This summary is machine-generated.

Retinoblastoma, a common infant eye cancer, is often hereditary and diagnosed via leukocoria or strabismus. Advances focus on conservative treatments to preserve vision and reduce enucleations.

Keywords:
childrenretinoblastoma

More Related Videos

Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
07:55

Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice

Published on: August 4, 2011

15.3K
Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases
07:46

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

1.6K

Related Experiment Videos

Last Updated: Apr 30, 2026

Reconstruct Human Retinoblastoma In Vitro
06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

1.6K
Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
07:55

Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice

Published on: August 4, 2011

15.3K
Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases
07:46

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

1.6K

Area of Science:

  • Ophthalmology and Oncology
  • Pediatric Cancer Genetics

Context:

  • Retinoblastoma is the most frequent intraocular malignancy in infants, affecting 1 in 15,000-20,000 births.
  • Hereditary forms, linked to RB1 gene mutations, account for bilateral and multifocal unilateral cases.
  • Key presenting symptoms include leukocoria (white pupil) and strabismus (crossed eyes).

Purpose:

  • To outline the diagnosis, treatment, and management of retinoblastoma.
  • To highlight recent advances in conservative treatment strategies.
  • To emphasize the importance of early detection and multidisciplinary care.

Summary:

  • Diagnosis involves fundoscopy, ultrasound, and MRI, considering disease extent and hereditary factors.
  • Treatment decisions balance ocular salvage, vision preservation, and hereditary risks.
  • Conservative treatments like chemotherapy, laser, and intra-arterial perfusion are increasingly used, reducing enucleations and radiotherapy.

Impact:

  • Improved survival rates in industrialized nations, with a focus on managing long-term risks like secondary tumors.
  • Conservative therapies aim to preserve visual function and minimize invasive procedures.
  • Multidisciplinary care and long-term follow-up are crucial for optimal patient outcomes and genetic counseling.